Diligence memo · auto-generated · as of July 2, 2026

Breast Microseed, Inc.

Breast Microseed, Inc. looks fair against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Breast Microseed, Inc. operates in Other Health Care, based in MERCER ISLAND.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Breast Microseed, Inc. has raised $12M in disclosed capital across 6 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).

Largest single filing: $7.5M on 2020-03-06.

Most recent recorded round closed around 2020-03-06.

Valuation (modeled)modeled

Provath models Breast Microseed, Inc. at approximately $144M (range $9.1M–$780M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 1.42× the median modeled value of Series A Other Health Care companies in 2019–2021 (164 peers) — value vs value, same stage and era. Within the normal band (142% of peer median) for its niche.

Financing rhythm & timingmixed

Historic cadence: a new round about every 7 months.

Last raise 6.3 yr ago; this sector typically re-raises about every 14 months.

Silent for over 3× the sector's normal cadence.

The last round was 1.0× smaller than the prior — a bridge or down round.

Comparablesmixed

Capital scale ranks ahead of 78% of Other Health Care peers (5377 compared).

Modeled value ranks above 84% of those peers.

Closest niche peers: InvestCo Tabletop, LLC, Mediphore, Inc., iVinci Partners, LLC, Oklahoma Proton Center LLC, MicroOptx, Inc..

Peoplefiled

21 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.